- Prison Planet.com - http://www.prisonplanet.com -

FDA Approves Deadly Enbrel Drug for Children

Posted By admin On November 12, 2008 @ 4:49 am In Sci Tech | Comments Disabled

David Gutierrez
NaturalNews [1]
Wednesday, Nov 12, 2008

An FDA advisory panel has recommended the approval of Amgen’s immune-suppressing drug Enbrel (generic name etanercept) for the treatment of psoriasis in children, in spite of ongoing concerns that the drug may have lethal side effects.

The recommendation came only two days after an independent panel recommended that the FDA strengthen Enbrel’s label with warnings about potentially fatal side effects such as anemia, seizures, serious infections, cancer or neurological problems. It also comes as the FDA [2] is investigating whether the entire drug family of which Enbrel is a part increases the risk of cancer [3] in children, particularly lymphoma.

The FDA is investigating 30 reports of cancer in children and young adults who have been treated with drugs in the family, known as tumor necrosis factor (TNF) blockers. Because TNF blockers interfere with the functioning of the immune system [4], they are used to treat autoimmune disorders such as Crohn’s disease or rheumatoid arthritis [5]. By the same token, however, they can dangerously weaken the body’s defenses, exposing it to serious infection or other problems.

(Article continues below)

FDA Approves Deadly Enbrel Drug for Children 161008pptv3 [6]

Enbrel is currently approved for the treatment of rheumatoid arthritis [7] in both adults and children, and for the treatment of moderate to severe psoriasis [8] in adults only. If the FDA follows its panel’s recommendation, as it usually does, children with moderate to severe psoriasis will also soon be treated with the drug.

One day earlier, the same advisory panel recommended the approval of another adult psoriasis drug: ustekinumab, manufactured by Johnson & Johnson. Only the week before, however, the FDA had issued a warning on its Web site that ustekinumab may increase the risk of cancer in those who take it.

People with psoriasis suffer from itchy or painful red, thick patches on the skin. The immune system is believed to play some role in mediating the disease [9].

Sources for the story include: www.washingtonpost.com [10].

Article printed from Prison Planet.com: http://www.prisonplanet.com

URL to article: http://www.prisonplanet.com/fda-approves-deadly-enbrel-drug-for-children.html

URLs in this post:

[1] NaturalNews: http://www.naturalnews.com/024781.html

[2] the FDA: http://www.naturalnews.com/the_FDA.html

[3] cancer: http://www.naturalnews.com/cancer.html

[4] immune system: http://www.naturalnews.com/immune_system.html

[5] rheumatoid arthritis: http://www.naturalnews.com/rheumatoid_arthritis.html

[6] Image: http://www.prisonplanet.tv/subscribe.html

[7] arthritis: http://www.naturalnews.com/arthritis.html

[8] psoriasis: http://www.naturalnews.com/psoriasis.html

[9] disease: http://www.naturalnews.com/disease.html

[10] www.washingtonpost.com: http://www.washingtonpost.com/

[11] Young Children Now Being Targeted For Statin Drug Use: http://www.prisonplanet.com/young-children-now-being-targeted-for-statin-drug-use.html

[12] Children as Big Pharma Guinea Pigs: 98 Percent of Drug Trials on Children Have no Safety Checks: http://www.prisonplanet.com/children-as-big-pharma-guinea-pigs-98-percent-of-drug-trials-on-children-have-no-safety-checks.html

[13] Man prescribed Big Pharma combo drug for IBS gets leukemia instead of relief: http://www.prisonplanet.com/man-prescribed-big-pharma-combo-drug-for-ibs-gets-leukemia-instead-of-relief.html

[14] FDA Approves New Big Pharma Pill Solution for Prescription Drug Addiction: http://www.prisonplanet.com/fda-approves-new-big-pharma-pill-solution-for-prescription-drug-addiction.html

[15] Adverse Drug Reactions Cover-Up? 80,000 Drug Files Go ‘Unreported’ by Big Pharma: http://www.prisonplanet.com/adverse-drug-reactions-cover-up-80000-drug-files-go-%e2%80%98unreported%e2%80%99-by-big-pharma.html

Copyright © 2013 PrisonPlanet.com. All rights reserved.